IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,109,000 | -21.5% | 700,000 | -6.7% | 1.20% | -19.7% |
| Q2 2023 | $14,152,500 | +205.2% | 750,000 | -40.0% | 1.49% | +193.1% |
| Q1 2023 | $4,637,500 | -37.7% | 1,250,000 | -16.7% | 0.51% | -34.4% |
| Q4 2022 | $7,440,000 | +13.9% | 1,500,000 | +36.4% | 0.78% | +13.5% |
| Q3 2022 | $6,534,000 | +21.0% | 1,100,000 | -8.3% | 0.68% | +11.4% |
| Q2 2022 | $5,400,000 | -20.4% | 1,200,000 | -15.8% | 0.61% | -8.2% |
| Q1 2022 | $6,783,000 | -39.3% | 1,425,000 | -5.0% | 0.67% | -10.0% |
| Q4 2021 | $11,175,000 | +61.7% | 1,500,000 | +23.1% | 0.74% | +53.2% |
| Q3 2021 | $6,911,000 | -14.0% | 1,218,850 | 0.0% | 0.48% | -11.0% |
| Q2 2021 | $8,032,000 | +80.3% | 1,218,850 | +121.6% | 0.54% | +75.2% |
| Q1 2021 | $4,455,000 | +133.7% | 550,000 | +205.6% | 0.31% | -44.3% |
| Q3 2014 | $1,906,000 | +62.9% | 180,000 | +82.4% | 0.56% | +60.8% |
| Q2 2014 | $1,170,000 | +6.4% | 98,702 | +33.9% | 0.35% | +5.2% |
| Q1 2014 | $1,100,000 | -25.0% | 73,702 | -26.3% | 0.33% | -42.5% |
| Q4 2013 | $1,467,000 | – | 100,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |